-
It is still at the mice testing stage, but 80% tested had a reversal of diabetes and in other cases it prevented the onset of diabetes. Side effects, etc. will need to be studied as well, but this looks very promising if in fact the drugs can prevent diabetes for many, especially children if their...
-
The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-02-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
-
10 genetic mutations were found in the patient's tumor and virtually every cell in the tumor sample had nine of the mutations. “What's striking about the new research is that the scientists were able to sift through the 3 billion pairs of chemical bases that make up the human genome to...
-
Even folks with money and in high positions have problems getting access to cancer drugs, as you can read below, and this was not an issue of not being able to afford the medication. When you read items as such, it makes you stop and think how precious life and healthcare really is. BD ...
-
According to the study, statins are lowering the PSA levels, but the concern is whether or not this could be hiding or clouding the issues and cancer could be potentially missed in the diagnosis as they are not sure if this is lowering the test numbers or if it is in fact helping in the prevention of...
-
It is here but evolving slower than what all of us might like to see, and in many areas it is still so much of a “Science” but as developments occur through biotech we are seeing some amazing results. There’s also the bridging of the gap with bringing genomics to the point of care, as physicians...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-26-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Biotech, Cancer, tumors, Genentech, Herceptin, cancer vaccine
-
One thing that comes to mind is what a waste of talent here. Series of events lead up to where he is today, but started when he ran out of money for his research related to the GFP gene and cancer. “Researchers worldwide now use GFP to track development of brain cells, the growth of tumors...
-
The UK continues to say “no” to cancer drugs due to price. If you stop and look at the prices for cancer drugs, something along the line here is going to need to balance soon. It is great and wonderful to have the R and D and great breakthroughs that are occurring almost daily, but what good does...
-
The costs of cancer treatment and associated drugs is rising as we all know. We are pouring money into R and D as fast as we can, and yes that does cost money, but insurers are making it hard to get insurance coverage and somewhere along the line you need to have a drug that is affordable as well...
-
If you are using or recommending this test, this might be of interest with the latest FDA action until it is determined if the the specifications meet the specifications as developed at Yale. BD The FDA has warned clinical-test giant LabCorp that it has been marketing an ovarian cancer test...
-
This is a touchy subject as you don’t want to diminish any funds that are coming in, yet some type of umbrella where perhaps all are connected may not be a bad idea. As mentioned too, the groups are able to help gain research funds to innovators that may not otherwise be able to get a traditional...
-
The risks are greater if you the glutathione S-transferase M1, or GSTM1 genes, so it appears we need to find out if we have that gene as females to see how risky talcum powder would be. I guess sooner or late we are all going to want to know more about our genes so we can figure out not only what...
-
The tool is designed for use by doctors and will still need to go through clinical trials to determine accuracy and effectiveness. This is a joint effort and will be tested at Harvard Medical School and the Cleveland Clinic. Radiation oncologists and urologists are the targeted physicians...
-
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-19-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
-
The debate over Medicare paying for this procedures has been up in the air for years, but now I believe the cost as well as convenience issue is starting to come together. CT Scanners have had this service available for years and it certainly is much easier for the patient, hands down. There is...